Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers.
Hugosson
J
J
Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden. jonas.hugosson@vgregion.se
Lilja
H
H
Lodding
P
P
Pihl
C G
CG
D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*